0001437749-23-024713.txt : 20230825
0001437749-23-024713.hdr.sgml : 20230825
20230825180101
ACCESSION NUMBER: 0001437749-23-024713
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230823
FILED AS OF DATE: 20230825
DATE AS OF CHANGE: 20230825
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Simonson Steven
CENTRAL INDEX KEY: 0001624401
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39290
FILM NUMBER: 231209558
MAIL ADDRESS:
STREET 1: 2600 KELLY ROAD, SUITE 100
CITY: WARRINGTON
STATE: PA
ZIP: 18976
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: WINDTREE THERAPEUTICS INC /DE/
CENTRAL INDEX KEY: 0000946486
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943171943
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2600 KELLY ROAD
STREET 2: SUITE 100
CITY: WARRINGTON
STATE: PA
ZIP: 18976
BUSINESS PHONE: 2154889300
MAIL ADDRESS:
STREET 1: 2600 KELLY ROAD
STREET 2: SUITE 100
CITY: WARRINGTON
STATE: PA
ZIP: 18976
FORMER COMPANY:
FORMER CONFORMED NAME: DISCOVERY LABORATORIES INC /DE/
DATE OF NAME CHANGE: 19971201
FORMER COMPANY:
FORMER CONFORMED NAME: ANSAN PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19961121
FORMER COMPANY:
FORMER CONFORMED NAME: ANSAN INC
DATE OF NAME CHANGE: 19950609
4
1
rdgdoc.xml
FORM 4
X0508
4
2023-08-23
0000946486
WINDTREE THERAPEUTICS INC /DE/
WINT
0001624401
Simonson Steven
2600 KELLY ROAD
SUITE 100
WARRINGTON
PA
18976
1
SVP, Chief Medical Officer
0
Common Stock
2023-08-23
4
A
0
15867
0
A
17440
D
Common Stock
6
I
By Trust
Employee Stock Option (Right to Buy)
1.21
2023-08-23
4
A
0
23800
0
A
2033-08-23
Common Stock
23800
23800
D
These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest with respect to one-third of the total number of shares subject to the RSUs on an annual basis (every 12 months) with the first vest date on August 23, 2024 provided that the reporting person remains in continuous service on each vesting date.
Holding amount represents issuer's matching stock contribution pursuant to 401(k) plan.
This employee stock option shall vest and become exercisable with respect to one-third of the total number of shares subject to the option on an annual basis (every 12 months) with the first vest date on August 23, 2024 provided that the reporting person remains in continuous service on each vesting date.
/s/ Jamie McAndrew, as Attorney-in-Fact
2023-08-25